Feedback / Questions
2-bromo-D-lysergic acid diethylamide (NYPRG-101) - Ceruvia Lifesci
https://www.prnewswire.co.uk/news-releases/ceruvia-lifesciences-announces-first-participant-dosed-in-bol-148-phase-1-clinical-trial-301722293.html
Jan 17, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next